Delivery Order 36F79724D0101-36C24925F0052
Award Date
10/18/24
Potential Completion Date
11/30/24
Potential Value
$314K
Federal Agency
Veterans Integrated Service Network 9
Awardee
Bristol-Myers Squibb Company
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lawrenceville, Lawrence Township, NJ 08648, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) to Bristol-Myers Squibb Company, a global biopharmaceutical manufacturer. The contract, valued at $338,932.84, is for the supply of ABECMA INJECTION, a chimeric antigen receptor (CAR) T cell therapy used for the treatment of certain types of cancer, including non-Hodgkin lymphoma and multiple myeloma. The contract supports the VA's Veterans Health Administration in providing advanced medical...
This is a delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Bristol-Myers Squibb Company for the provision of ABECMA, a chimeric antigen receptor (CAR) T cell therapy, for use in transplant injections. The contract has a firm fixed price of $338,932.84 and an ultimate completion date of May 17, 2025. The contract is a task order under Bristol-Myers Squibb's $12.28 billion Federal Supply Schedule (FSS) contract with the VA, which covers a wide range of drugs,...
This is a federal contract award to Bristol-Myers Squibb Company, doing business as Bristol-Myers Squibb, for the delivery of the ABECMA chimeric antigen receptor (CAR) T cell immunotherapy. The award, valued at $314,322.29, is a delivery order placed against Bristol-Myers Squibb's existing Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs Veterans Health Administration (VA VHA). This multiple award FSS contract has a ceiling value of $12,278,876,570.00 and runs...
The Department of Veterans Affairs Veterans Health Administration awarded a delivery order contract to Bristol-Myers Squibb Company for the pharmaceutical product IDECABTAGENE VICLEUCEL INJ,SUSP (ABECMA). This order was issued under Bristol-Myers Squibb's Pharmaceuticals and Drugs Federal Supply Schedule contract, using a firm fixed price payment structure. The potential value of the order is $314,322.29, with a performance period running through April 5, 2024. No set-aside designation was...
This federal contract award is for the delivery of ABECMA (idecabtagene vicleucel) injections to the U.S. Department of Veterans Affairs (VA) healthcare system. The prime contractor is Bristol-Myers Squibb Company, a global biopharmaceutical firm that specializes in oncology and immunotherapy products. This delivery order, valued at $314,322.29, is placed against Bristol-Myers Squibb's existing Federal Supply Schedule (FSS) contract with the VA (ID: 36F79724D0101), which has a ceiling value of...
This is a federal contract award to Bristol-Myers Squibb Company, a global biopharmaceutical company, for the delivery of ABECMA, a chimeric antigen receptor (CAR) T-cell therapy. The $338,932.84 firm fixed-price delivery order contract was awarded on October 9, 2025 by the Department of Veterans Affairs (VA) and has an ultimate completion date of January 8, 2026. The contract is funded through the VA's Veterans Integrated Service Network 9 and is not designated as a set-aside. The contract is...
This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) to Bristol-Myers Squibb Company, a global biopharmaceutical manufacturer, for the provision of ABECMA, a chimeric antigen receptor (CAR) T cell therapy used to treat transplant patients. The order, valued at $338,932.84, is part of a larger $12.28 billion Federal Supply Schedule contract (ID: 36F79724D0101) that enables the VA to efficiently procure a wide range of drugs, pharmaceuticals, and...
This is a delivery order awarded by the Department of Veterans Affairs (VA) to Bristol-Myers Squibb Company, a global biopharmaceutical manufacturer. The $338,932.84 firm fixed-price order is for the ABECMA CAR T cell therapy, which is used to treat various types of cancer, including non-Hodgkin lymphoma and multiple myeloma. The contract is not set aside and is issued under Bristol-Myers Squibb's existing Federal Supply Schedule (FSS) contract with the VA, valued at $12,278,876,570.00 and...
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Bristol-Myers Squibb Company for the provision of ABECMA, a chimeric antigen receptor (CAR) T cell therapy, for use in transplant procedures. The order, worth $338,932.84, is part of a larger multiple-award Federal Supply Schedule (FSS) contract between the VA and Bristol-Myers Squibb, which has a ceiling value of $12,278,876,570.00 and runs through April 2029. This FSS contract covers a broad range...
The Department of Veterans Affairs Veterans Health Administration awarded a delivery order contract to Bristol-Myers Squibb Company, doing business as Bristol-Myers Squibb, a global biopharmaceutical company. The $314,322.29 firm fixed price contract is for the provision of IDECABTAGENE VICLEUCEL, with a period of performance from March 20, 2024 to April 30, 2024. This delivery order is part of Bristol-Myers Squibb's broader Federal Supply Schedule contract with the Department of Veterans...